Feeder-free generation of endocardial and endothelial populations from iPSCs
(A) Schematic of differentiation timeline.
(B) Flow cytometry plots assessing mesoderm generation on day 4 of their respective differentiation strategies.
(C) Quantification of CD13+/CD56+ mesoderm generation (n = 4, ∗p < 0.05, two-way ANOVA with Sidak’s multiple comparisons test, error bars ±SEM).
(D) Flow cytometry plots assessing endocardial/endothelial differentiation efficiency on day 14 (also see Figure S1).
(E) Timeline of CD31+ endocardial differentiation on days 10, 12, and 14 (n = 4, ∗p < 0.05 for WTC11, ##p < 0.01 for MSN02-4, two-way ANOVA with Dunnett’s multiple comparisons test, error bars ±SEM).
(F) Quantification of CD31+ endocardial efficiency on day 14 (n = 5, ∗p < 0.05, two-way ANOVA with Sidak’s multiple comparisons test, error bars ±SEM).